Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Denali Therapeutics Inc. has filed 775 SEC EDGAR filings since 08 Sep 2017

SEC filing history

Showing 376-400 of 775 matching filings.

Per page
25
Current page
16
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Feb 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Feb 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Feb 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Feb 2022
Reporting date
09 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SCHEDULE 13G/A

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

ARCH VENTURE FUND VIII, L.P. - DENALI THERAPEUTICS INC. -- SCH 13G/A (#3E)

Filing date
08 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Feb 2022
Reporting date
03 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Feb 2022
Reporting date
03 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
18 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jan 2022
Reporting date
08 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2022
Reporting date
05 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2022
Reporting date
05 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2022
Reporting date
05 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2022
Reporting date
05 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .